1. Home
  2. DGX vs TEVA Comparison

DGX vs TEVA Comparison

Compare DGX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGX
  • TEVA
  • Stock Information
  • Founded
  • DGX 1967
  • TEVA 1901
  • Country
  • DGX United States
  • TEVA Israel
  • Employees
  • DGX N/A
  • TEVA N/A
  • Industry
  • DGX Medical Specialities
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGX Health Care
  • TEVA Health Care
  • Exchange
  • DGX Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • DGX 20.5B
  • TEVA 21.2B
  • IPO Year
  • DGX 1996
  • TEVA N/A
  • Fundamental
  • Price
  • DGX $192.77
  • TEVA $24.99
  • Analyst Decision
  • DGX Buy
  • TEVA Strong Buy
  • Analyst Count
  • DGX 15
  • TEVA 7
  • Target Price
  • DGX $194.07
  • TEVA $25.86
  • AVG Volume (30 Days)
  • DGX 1.2M
  • TEVA 14.1M
  • Earning Date
  • DGX 10-21-2025
  • TEVA 11-05-2025
  • Dividend Yield
  • DGX 1.68%
  • TEVA N/A
  • EPS Growth
  • DGX 14.49
  • TEVA N/A
  • EPS
  • DGX 8.51
  • TEVA 0.62
  • Revenue
  • DGX $10,850,000,000.00
  • TEVA $16,776,000,000.00
  • Revenue This Year
  • DGX $12.37
  • TEVA $4.11
  • Revenue Next Year
  • DGX $3.51
  • TEVA $0.40
  • P/E Ratio
  • DGX $22.40
  • TEVA $39.23
  • Revenue Growth
  • DGX 13.74
  • TEVA 0.02
  • 52 Week Low
  • DGX $148.70
  • TEVA $12.47
  • 52 Week High
  • DGX $197.55
  • TEVA $26.38
  • Technical
  • Relative Strength Index (RSI)
  • DGX 66.25
  • TEVA 67.85
  • Support Level
  • DGX $184.18
  • TEVA $24.01
  • Resistance Level
  • DGX $193.76
  • TEVA $26.38
  • Average True Range (ATR)
  • DGX 4.26
  • TEVA 0.78
  • MACD
  • DGX 1.01
  • TEVA -0.08
  • Stochastic Oscillator
  • DGX 95.80
  • TEVA 50.90

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: